Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

Diagnostic Accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the Evaluation of Recurrent Papillary Thyroid Carcinoma With Patient's Raised Thyroglobulin Level in Lahore

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07062211

Enrollment

Registered

2025-07-14

Start date

2025-03-17

Completion date

2026-03-01

Last updated

2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Carcinoma

Brief summary

This research will employ cross-sectional analytical to determine diagnostic accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the evaluation of Recurrent Papillary Thyroid Carcinoma with patient's raised Thyroglobulin level in Lahore.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients include both male and female from 18years to 80years * Patients presented with raised thyroglobulin * Patients with suspected diagnosis of recurrent papillary thyroid carcinoma

Exclusion criteria

* Patients exclude both male and female below 18years and above 80years * All the patients presented with carcinoma other than papillary carcinoma. * All the patients with normal thyroglobulin level.

Design outcomes

Primary

Measure	Time frame	Description
Nominal self admsinitered questioner	12 Months	Scoring in a nominal scale involves assigning a unique numerical or symbolic code to each category. For instance, in a gender survey, you might code male as 1 and female as 2. However, these codes are purely for identification and do not imply any order or magnitude

Countries

Pakistan

Outcome results